Nothing Special   »   [go: up one dir, main page]
create a website
Role of Socioeconomic Status on Consumers’ Attitudes Towards DTCA of Prescription Medicines in Australia. (2012). Lee, Johnson ; Chaar, Betty .
In: Journal of Business Ethics.
RePEc:kap:jbuset:v:105:y:2012:i:4:p:447-460.

Full description at Econpapers || Download paper

Cited: 1

Citations received by this document

Cites: 43

References cited by this document

Cocites: 32

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. How Human–Chatbot Interaction Impairs Charitable Giving: The Role of Moral Judgment. (2022). Yang, Zhi Lin ; He, Yuanqiong ; Fei, Zhuoying ; Zhou, Yuanyuan.
    In: Journal of Business Ethics.
    RePEc:kap:jbuset:v:178:y:2022:i:3:d:10.1007_s10551-022-05045-w.

    Full description at Econpapers || Download paper

References

References cited by this document

  1. Australian Bureau of Statistics. (2006). Socioeconomic indexes for areas (SEIFA) Postal Areas. Australian Bureau of Statistics. Accessed June 13, 2009, from http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/2033.0.55.001Mai n+Features12006?OpenDocument .
    Paper not yet in RePEc: Add citation now
  2. Auton, F. (2004). The advertising of pharmaceuticals direct to patients: A critical review of the literature and debate. International Journal of Advertising, 23(1), 5–52.
    Paper not yet in RePEc: Add citation now
  3. Beauchamp, T., & Childress, J. (2009). Principles of biomedical ethics (6th ed.). New York: Oxford University Press.
    Paper not yet in RePEc: Add citation now
  4. Boden, W. E., & Diamond, G. A. (2008). DTCA for PTCA—Crossing the line in consumer health education? Perspective. New England Journal of Medicine, 358, 21.
    Paper not yet in RePEc: Add citation now
  5. Bonaccorso, S. N., & Sturchio, J. L. (2002). For and against: Direct to consumer advertising is medicalising normal human experience. British Medical Journal, 324, 910–911.
    Paper not yet in RePEc: Add citation now

  6. Brekke, K. R., & Kuhn, M. (2006). Direct to consumer advertising in pharmaceutical markets. Journal of Health Economics, 25(1), 102–130.

  7. Centrelink. (2009). Low income health care card. Commonwealth of Australia. Accessed October 24, 2009, from http://www.centrelink.gov.au/internet/internet.nsf/payments/con c_cards_iat.htm .
    Paper not yet in RePEc: Add citation now
  8. Chaar, B., & Kwong, K. (2010). Direct-to-consumer advertising: Australian pharmacists’ experiences with non-prescription medicines. International Journal of Pharmacy Practice, 18, 43–50.
    Paper not yet in RePEc: Add citation now
  9. Cleanthous, P. (2002). Patient welfare implications of innovation and diffusion in the US antidepressant market. Working Paper, New York University.
    Paper not yet in RePEc: Add citation now
  10. Cleanthous, P. (2004). Analyzing the effects of marketing efforts by pharmaceuticals on patient welfare. Working Paper, New York University.
    Paper not yet in RePEc: Add citation now
  11. Davis, J. J. (2007). Consumers’ preferences for the communication of risk information in drug advertising. Health Affairs, 26, 863–870.
    Paper not yet in RePEc: Add citation now
  12. Davis, K., Schoen, C., Schoenbaum, S. C., Doty, M. M., Holmgren, A. L., Kriss, J. L., et al. (2007). Mirror, mirror on the wall: An international update on the comparative performance of American health care. The Commonwealth Fund. Accessed October 24, 2009, from http://www.commonwealthfund.org/usr_doc/1027_davis_mirror_mirro r_international_update_final.pdf?section=4039 .
    Paper not yet in RePEc: Add citation now
  13. Department of Health and Ageing. (2005). Overview of the Australian healthcare system. Department of Health and Ageing. Accessed 12 October 12, 2009, from http://www.health.gov.au/internet/main/publishing.nsf/Content/h ealthsystem-overview-3-funding .
    Paper not yet in RePEc: Add citation now
  14. Department of Health and Ageing. (2008). Quality use of medicines. Commonwealth of Australia. Accessed October 15, 2009, from http://www.health.gov.au/internet/main/Publishing.nsf/Content/n mp-quality.htm .
    Paper not yet in RePEc: Add citation now
  15. Department of Health and Ageing. (2009). About the PBS. Commonwealth of Australia. Accessed October 24, 2009, from http://www.drinkingnightmare.gov.au/internet/main/publishing.ns f/Content/health-pbs-general-aboutus.htm-copy2 .
    Paper not yet in RePEc: Add citation now
  16. Desselle, S., & Aparasu, R. (2000). Attitudinal dimensions that determine pharmacists’ decisions to support direct-to-consumer advertising of prescription medicines. Drug Information Journal, 34, 103–114.
    Paper not yet in RePEc: Add citation now
  17. Donohue, M., Cevasco, M., & Rosenthal, M. B. (2007). A decade of direct-to-consumer advertising of prescription drugs. New England Journal of Medicine, 357, 673–681.
    Paper not yet in RePEc: Add citation now
  18. Fetto, J. (2002). Drugged out. American Demographics, 24, 11.
    Paper not yet in RePEc: Add citation now
  19. Galbally, R. (2001). Review of drugs poisons and controlled substances legislation. Final Report. Canberra: Commonwealth of Australia. Accessed September 03, 2010, from http://www.tga.gov.au/docs/html/rdpdfr.htm .
    Paper not yet in RePEc: Add citation now
  20. GAO. (2006). Prescription drugs: Improvements needed in FDA’s oversight of direct-to-consumer advertising. Report No. 07-54. United States General Accounting Office. Accessed September, 2010, from http://www.gao.gov/new.items/d0754.pdf .
    Paper not yet in RePEc: Add citation now
  21. Gardner, D. M., Mintzes, B., & Ostry, A. (2003). Direct-to-consumer prescription drug advertising in Canada: Permission by default? Canadian Medical Association Journal, 169, 425–427.
    Paper not yet in RePEc: Add citation now
  22. Gascione, D. (2004). DTC at the crossroads: A “direct” hit… or miss? IMS issues and insights, September 23, 2004, pp. 111–123. Plymouth Meeting, PA: IMS Health.
    Paper not yet in RePEc: Add citation now
  23. Gilbody, S., Wilson, P., & Watt, I. (2005). Benefits and harms of direct to consumer advertising: A systematic review. Quality and Safety in Health Care, 14(4), 246–250.
    Paper not yet in RePEc: Add citation now
  24. Gillon, R. (2003). Ethics needs principles—four can encompass the rest—and respect for autonomy should be “first among equals”. Journal of Medical Ethics, 29(5), 307–312.
    Paper not yet in RePEc: Add citation now
  25. Hall, D. V., & Jones, S. C. (2008). Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements. Australian and New Zealand Journal of Public Health, 32(5), 471–478.
    Paper not yet in RePEc: Add citation now
  26. Hansen, R., Schommer, J., Cline, R., Hadsall, R., Schondelmeyer, S., & Nyman, J. (2005). The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. Research in Social and Administrative Pharmacy, 1, 139–157.
    Paper not yet in RePEc: Add citation now
  27. Hoek, J., & Gendall, P. (2002). To have or not to have? Ethics and regulation of direct to consumer advertising of prescription medication. Journal of Marketing Communications, 8, 71–85.
    Paper not yet in RePEc: Add citation now
  28. Joseph, M., Spake, D. F., & Finney, Z. (2008). Consumer attitudes toward pharmaceutical direct-to-consumer advertising: An empirical study and the role of income. International Journal of Pharmaceutical and Healthcare Marketing, 2(2), 33–177.
    Paper not yet in RePEc: Add citation now
  29. Kerridge, I., Lowe, M., & Stewart, C. (2009). Ethics and law for the health professions (3rd ed., pp. 79–90). Annandale: The Federation Press.
    Paper not yet in RePEc: Add citation now
  30. Medicines Australia. (2008). Pharmaceutical benefits scheme quarterly fact sheet. Commonwealth of Australia. Accessed October 24, 2009, from http://www.medicinesaustralia.com.au/pages/images/PBS-Quarterly -facts-June-Quarter-2008.pdf .
    Paper not yet in RePEc: Add citation now
  31. Miller, K. E., & Waller, D. S. (2004). Attitudes towards DTC advertising in Australia: An exploratory study. International Journal of Advertising, 23(3), 389–405.
    Paper not yet in RePEc: Add citation now
  32. Mintzes, B. (2006). What are the public health implications? Direct-to-consumer advertising of prescription drugs in Canada. Health Council of Canada. Accessed June 15, 2009, from http://www.healthcouncilcanada.ca/docs/papers/2006/hcc_dtc-adve rtising_200601_e_v6.pdf .
    Paper not yet in RePEc: Add citation now
  33. Mintzes, B., & HAI Europe. (1998). Blurring the boundaries—New trends in drug promotion. Accessed January 24, 2011, from http://www.haiweb.org/pubs/blurring/blurring.intro.html .
    Paper not yet in RePEc: Add citation now
  34. Morgan, S. G., Mintzes, B., & Barer, M. L. (2003). The economics of direct-to-consumer advertising of prescription-only drugs: Prescribed to improve consumer welfare? International Journal of Health Services Research and Policy, 8(4), 237–244.
    Paper not yet in RePEc: Add citation now
  35. National Prescribing Service (NPS). (2009). Proton pump inhibitors-prescribing practice review for primary care. RADAR, 1–4.
    Paper not yet in RePEc: Add citation now
  36. Poser, M. (2010). DTCA of prescription medicines in the European Union: Is there still a need for a ban? European Journal of Health Law, 17, 471–484. doi: 10.1163/157180910X527897 .
    Paper not yet in RePEc: Add citation now
  37. Prat, P. (2000). The results of a regulatory compliance survey of direct-to-consumer advertisements for medicines. Wellington: Ministry of Health (Medsafe).
    Paper not yet in RePEc: Add citation now
  38. Semin, S., Aras, S., & Guldal, D. (2007). Direct to consumer advertising of pharmaceuticals: Developed countries’ experiences and Turkey. Health Expectations, 10(1), 4–15.
    Paper not yet in RePEc: Add citation now
  39. Silver, L. S., Stevens, R. E., & Loudon, D. (2009). Direct-to-consumer advertising of pharmaceuticals: Concepts, issues, and research. Health Marketing Quarterly, 26(4), 251–258.
    Paper not yet in RePEc: Add citation now
  40. Sub-Committee DU. (2008). Top 10 drugs. Commonwealth of Australia. Accessed October 21, 2009, from http://www.australianprescriber.com/upload/pdf/articles/992.pdf .
    Paper not yet in RePEc: Add citation now
  41. Weissman, J. S., Blumenthal, D., Silk, A. J., Newman, M., Zapert, K., Leitman, R., et al. (2004). Physicians report on patient encounters involving direct-to-consumer advertising. Accessed October 21, 2009, from http://content.healthaffairs.org/cgi/content/abstract/hlthaff.w 4.219 .
    Paper not yet in RePEc: Add citation now
  42. WHO. (1988). Ethical criteria for medicinal drug promotion. The World Health Organisation. Accessed June 14, 2009, from http://whqlibdoc.who.int/publications/1988/924154239X_eng.pdf .
    Paper not yet in RePEc: Add citation now
  43. Williams, J. R., & Hensel, P. J. (1995). Direct-to-consumer advertising of prescription drugs. Journal of Health Care Marketing, 15(1), 35–41.
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. Competing with precision: incentives for developing predictive biomarker tests. (2022). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R.
    In: Discussion Paper Series in Economics.
    RePEc:hhs:nhheco:2022_006.

    Full description at Econpapers || Download paper

  2. Analysis of Risk Factors in the Channels of Drug Distribution: Professional Perspectives. (2020). Fajsi, Angela ; Moraa, Slobodan ; Gruji, Jelena.
    In: Sustainability.
    RePEc:gam:jsusta:v:12:y:2020:i:11:p:4787-:d:370184.

    Full description at Econpapers || Download paper

  3. The Unexpected Consequences of Generic Entry. (2019). Ornaghi, Carmine ; Castanheira, Micael ; Siotis, Georges ; de Moura, Micael Castanheira .
    In: ULB Institutional Repository.
    RePEc:ulb:ulbeco:2013/298643.

    Full description at Econpapers || Download paper

  4. The unexpected consequences of generic entry. (2019). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:68:y:2019:i:c:s0167629618305332.

    Full description at Econpapers || Download paper

  5. The Unexpected Consequences of Generic Entry. (2019). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael.
    In: Working Papers ECARES.
    RePEc:eca:wpaper:2013/293928.

    Full description at Econpapers || Download paper

  6. Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws. (2018). Richards, Michael R ; Nathenson, Robert.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:18:y:2018:i:3:d:10.1007_s10754-018-9234-3.

    Full description at Econpapers || Download paper

  7. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication. (2015). Bradford, W. David ; Kleit, Andrew N..
    In: Health Economics.
    RePEc:wly:hlthec:v:24:y:2015:i:7:p:859-875.

    Full description at Econpapers || Download paper

  8. The effects of direct-to-consumer advertising of pharmaceuticals on adherence. (2015). , Cardon .
    In: Applied Economics.
    RePEc:taf:applec:v:47:y:2015:i:50:p:5432-5444.

    Full description at Econpapers || Download paper

  9. The Regulation of Direct-to-Consumer Advertising of Pharmaceuticals in a Managed Care Setting. (2015). Ryan, Matthew ; Vaithianathan, Rhema .
    In: Journal of Public Economic Theory.
    RePEc:bla:jpbect:v:17:y:2015:i:6:p:986-1021.

    Full description at Econpapers || Download paper

  10. Effects of Pharmaceutical Promotion: A Review and Assessment. (2013). Dave, Dhaval.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:18830.

    Full description at Econpapers || Download paper

  11. The Relationship Between DTCA, Drug Requests, and Prescriptions: Uncovering Variation in Specialty and Space. (2013). Venkataraman, Sriram ; Landsman, Vardit ; Stremersch, Stefan .
    In: Marketing Science.
    RePEc:inm:ormksc:v:32:y:2013:i:1:p:89-110.

    Full description at Econpapers || Download paper

  12. Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?. (2013). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:32:y:2013:i:1:p:268-285.

    Full description at Econpapers || Download paper

  13. Informing the uninformed: How drug advertising affects check-up visits. (2013). Wendling, Brett ; Hosken, Daniel .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:2:p:181-194.

    Full description at Econpapers || Download paper

  14. Direct-to-consumer advertising and consumer welfare. (2013). Jayawardhana, Jayani .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:2:p:164-180.

    Full description at Econpapers || Download paper

  15. Quality competition with motivated providers and sluggish demand. (2013). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto.
    In: Journal of Economic Dynamics and Control.
    RePEc:eee:dyncon:v:37:y:2013:i:10:p:2041-2061.

    Full description at Econpapers || Download paper

  16. Impact of Direct?to?Consumer Advertising on Pharmaceutical Prices and Demand. (2012). Saffer, Henry ; Dave, Dhaval.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:79:y:2012:i:1:p:97-126.

    Full description at Econpapers || Download paper

  17. Misleading advertising in duopoly. (2012). Hattori, Keisuke ; Higashida, Keisaku.
    In: Canadian Journal of Economics/Revue canadienne d'économique.
    RePEc:wly:canjec:v:45:y:2012:i:3:p:1154-1187.

    Full description at Econpapers || Download paper

  18. Role of Socioeconomic Status on Consumers’ Attitudes Towards DTCA of Prescription Medicines in Australia. (2012). Lee, Johnson ; Chaar, Betty .
    In: Journal of Business Ethics.
    RePEc:kap:jbuset:v:105:y:2012:i:4:p:447-460.

    Full description at Econpapers || Download paper

  19. Can Credence Advertising Effects Be Isolated? Can They Be Negative?: Evidence from Pharmaceuticals. (2011). Kleit, Andrew N ; Bradford, David W.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:78:y:2011:i:1:p:167-190.

    Full description at Econpapers || Download paper

  20. Side Effects of Competition: the Role of Advertising and Promotion in Pharmaceutical Markets. (2011). Markowitz, Sara ; David, Guy.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:17162.

    Full description at Econpapers || Download paper

  21. Competition and quality in health care markets: A differential-game approach. (2010). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto ; Brekke, Kurt.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:29:y:2010:i:4:p:508-523.

    Full description at Econpapers || Download paper

  22. Marketing and societal welfare: A multiple stakeholder approach. (2010). Matear, Margaret ; Dacin, Peter A..
    In: Journal of Business Research.
    RePEc:eee:jbrese:v:63:y:2010:i:11:p:1173-1178.

    Full description at Econpapers || Download paper

  23. Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?. (2010). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:8076.

    Full description at Econpapers || Download paper

  24. The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation. (2010). Richards-Shubik, Seth ; Markowitz, Sara ; David, Guy.
    In: American Economic Journal: Economic Policy.
    RePEc:aea:aejpol:v:2:y:2010:i:4:p:1-25.

    Full description at Econpapers || Download paper

  25. Trials, tricks and transparency: How disclosure rules affect clinical knowledge. (2009). Porteiro, Nicolás ; González, Paula ; Dahm, Matthias ; Gonzalez, Paula.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:28:y:2009:i:6:p:1141-1153.

    Full description at Econpapers || Download paper

  26. Competition and quality in regulated markets: a differential-game approach. (2008). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto ; Brekke, Kurt.
    In: Discussion Papers.
    RePEc:yor:yorken:08/05.

    Full description at Econpapers || Download paper

  27. Competition and Quality in Regulated Markets: a Differential-Game Approach. (2008). Straume, Odd Rune ; Siciliani, Luigi ; Cellini, Roberto ; Brekke, Kurt.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:6801.

    Full description at Econpapers || Download paper

  28. Pharmaceutical Patents: Incentives for R&D or Marketing?. (2008). Straume, Odd Rune ; Brekke, Kurt.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_2433.

    Full description at Econpapers || Download paper

  29. Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs. (2008). Linnosmaa, Ismo.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:8:y:2008:i:2:n:8.

    Full description at Econpapers || Download paper

  30. Sustaining Social Security. (2007). Niepelt, Dirk ; Gonzalez-Eiras, Martin.
    In: 2007 Meeting Papers.
    RePEc:red:sed007:95.

    Full description at Econpapers || Download paper

  31. Advertising and generic market entry. (2007). Konigbauer, Ingrid .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:26:y:2007:i:2:p:286-305.

    Full description at Econpapers || Download paper

  32. Dealing with Rising Health Care Costs: The Case of Pharmaceuticals. (2006). Konigbauer, Ingrid .
    In: Munich Dissertations in Economics.
    RePEc:lmu:dissen:5640.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-03-06 15:25:55 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.